FDA mandates new opioid labeling to highlight long-term risks, aiming to combat addiction and improve patient safety in pain ...

The U.S. Food and Drug Administration is requiring major safety labeling changes for all opioid pain medications, warning about addiction, overdose and long-term risks.

The FDA has released a report to educate the public regarding the dangers of 7-OH and its distinction from the kratom plant ...